These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 36369745

  • 21. The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience.
    Kogan-Liberman D, Burroughs M, Emre S, Moscona A, Shneider BL.
    J Pediatr Gastroenterol Nutr; 2001 Oct; 33(4):445-9. PubMed ID: 11698761
    [Abstract] [Full Text] [Related]

  • 22. Association between Epstein-Barr virus seroconversion and immunohistochemical changes in tonsils of pediatric solid organ transplant recipients.
    Shapiro NL, Tang CG, Bhattacharyya N.
    Laryngoscope; 2011 Aug; 121(8):1718-25. PubMed ID: 21792960
    [Abstract] [Full Text] [Related]

  • 23. Epstein-Barr Virus DNAemia and post-transplant lymphoproliferative disorder in pediatric solid organ transplant recipients.
    Chang YC, Young RR, Mavis AM, Chambers ET, Kirmani S, Kelly MS, Kalu IC, Smith MJ, Lugo DJ.
    PLoS One; 2022 Aug; 17(10):e0269766. PubMed ID: 36256635
    [Abstract] [Full Text] [Related]

  • 24. The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation.
    Green M, Reyes J, Webber S, Rowe D.
    Transpl Infect Dis; 2001 Jun; 3(2):97-103. PubMed ID: 11395975
    [Abstract] [Full Text] [Related]

  • 25. Presentation and outcomes of post-transplant lymphoproliferative disorder at a single institution pediatric transplant center.
    Ramos-Gonzalez G, Crum R, Allain A, Agur T, O'Melia L, Staffa S, Burchett SK, Siegele B, Weinberg O, Rodig NM, Fawaz R, Singh TP, Freiberger DA, Bae Kim H.
    Pediatr Transplant; 2022 Aug; 26(5):e14268. PubMed ID: 35304794
    [Abstract] [Full Text] [Related]

  • 26. Post-transplant lymphoproliferative disorders.
    Dharnidharka VR, Webster AC, Martinez OM, Preiksaitis JK, Leblond V, Choquet S.
    Nat Rev Dis Primers; 2016 Jan 28; 2():15088. PubMed ID: 27189056
    [Abstract] [Full Text] [Related]

  • 27. Early evidence of lymphoproliferative disorder: post-transplant monitoring of Epstein-Barr infection in adult and pediatric patients.
    Gaeta A, Nazzari C, Verzaro S, Latte MC, Fabri G, Scateni S, Raggi C, Lubrano R, Mancini C.
    New Microbiol; 2006 Oct 28; 29(4):231-41. PubMed ID: 17201089
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Quantitative Epstein-Barr virus shedding and its correlation with the risk of post-transplant lymphoproliferative disorder.
    Holman CJ, Karger AB, Mullan BD, Brundage RC, Balfour HH.
    Clin Transplant; 2012 Oct 28; 26(5):741-7. PubMed ID: 22385033
    [Abstract] [Full Text] [Related]

  • 30. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56dimNKG2A+KIR- NK Cells and Contributes to Suboptimal Control of EBV in Immunosuppressed Children With Post-transplant Lymphoproliferative Disorder.
    Lam JKP, Azzi T, Hui KF, Wong AMG, McHugh D, Caduff N, Chan KH, Münz C, Chiang AKS.
    Front Immunol; 2020 Oct 28; 11():1231. PubMed ID: 32625211
    [Abstract] [Full Text] [Related]

  • 31. Epstein-Barr virus-associated post-transplant lymphoproliferative disorders in pediatric transplantation: A prospective multicenter study in the United States.
    Tajima T, Martinez OM, Bernstein D, Boyd SD, Gratzinger D, Lum G, Sasaki K, Tan B, Twist CJ, Weinberg K, Armstrong B, Desai DM, Mazariegos GV, Chin C, Fishbein TM, Tekin A, Venick RS, Krams SM, Esquivel CO.
    Pediatr Transplant; 2024 Jun 28; 28(4):e14763. PubMed ID: 38682750
    [Abstract] [Full Text] [Related]

  • 32. Post-transplant lymphoproliferative disorder.
    Kalinova L, Indrakova J, Bachleda P.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Dec 28; 153(4):251-7. PubMed ID: 20208963
    [Abstract] [Full Text] [Related]

  • 33. Case Report: Non-negligible Epstein-Barr virus-associated posttransplant lymphoproliferative disorders in a lung transplant recipient.
    Hu J, Yu YW, Han DS, Li XJ, Zhang YQ, Cai HL, Xiao YH, Zheng X.
    Front Immunol; 2023 Dec 28; 14():1244534. PubMed ID: 37781359
    [Abstract] [Full Text] [Related]

  • 34. Post-transplant lymphoproliferative disorders and Epstein-Barr virus DNAemia in a cohort of lung transplant recipients.
    Baldanti F, Rognoni V, Cascina A, Oggionni T, Tinelli C, Meloni F.
    Virol J; 2011 Sep 05; 8():421. PubMed ID: 21892950
    [Abstract] [Full Text] [Related]

  • 35. Management of post-transplant lymphoproliferative disorders.
    Llaurador G, McLaughlin L, Wistinghausen B.
    Curr Opin Pediatr; 2017 Feb 05; 29(1):34-40. PubMed ID: 27906865
    [Abstract] [Full Text] [Related]

  • 36. Management of Epstein-Barr virus-induced post-transplant lymphoproliferative disease in recipients of solid organ transplantation.
    Green M.
    Am J Transplant; 2001 Jul 05; 1(2):103-8. PubMed ID: 12099356
    [Abstract] [Full Text] [Related]

  • 37. Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting.
    Paya CV, Fung JJ, Nalesnik MA, Kieff E, Green M, Gores G, Habermann TM, Wiesner PH, Swinnen JL, Woodle ES, Bromberg JS.
    Transplantation; 1999 Nov 27; 68(10):1517-25. PubMed ID: 10589949
    [Abstract] [Full Text] [Related]

  • 38. Post-transplant lymphoproliferative disorders.
    Singavi AK, Harrington AM, Fenske TS.
    Cancer Treat Res; 2015 Nov 27; 165():305-27. PubMed ID: 25655616
    [Abstract] [Full Text] [Related]

  • 39. Association between HLA-A1 and -A2 types and Epstein-Barr virus status of post-transplant lymphoproliferative disorder.
    Kinch A, Sundström C, Tufveson G, Glimelius I.
    Leuk Lymphoma; 2016 Oct 27; 57(10):2351-8. PubMed ID: 27104753
    [Abstract] [Full Text] [Related]

  • 40. [Post-transplant lymphoproliferative disorders].
    Forsell S, Lang N.
    Rev Med Suisse; 2023 May 17; 19(827):964-968. PubMed ID: 37195110
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.